VCP ScannerFree US Stock Screener & Financial AnalysisFree US Stock Screener

Biodexa Pharmaceuticals Plc (BDRX) Total Return Calculator with Dividends Reinvested

Biodexa Pharmaceuticals Plc

Popular:

The total return for Biodexa Pharmaceuticals Plc (BDRX) stock is -92.96% over the past 12 months. So far it's down 60.49% this year. The 5-year total return is -100.00%, meaning $10,000 invested in BDRX stock 5 years ago would be worth $0 today. Total return includes price appreciation plus reinvesting any dividends paid out.

If you invested $10,000 in BDRX 1 year ago, it would be worth $689 today — you'd have lost $9,311.

With Dividends Reinvested$689-93.11%

Price Only (No DRIP)$689-93.11%

Period2025-05-08 → 2026-05-07

Price

Total Return (DRIP)

S&P 500

If You Invested $10,000 in BDRX

1Y$704-$9,296 (-93.0%)-93.0% CAGR

3Y$2-$9,998 (-100.0%)-94.0% CAGR

5Y$0-$10,000 (-100.0%)-91.3% CAGR

10Y$0-$10,000 (-100.0%)-70.5% CAGR

15Y$0-$10,000 (-100.0%)-55.7% CAGR

20Y$0-$10,000 (-100.0%)-45.7% CAGR

30Y$0-$10,000 (-100.0%)-33.4% CAGR

Biodexa Pharmaceuticals Plc did not pay dividends during this period. Total return = price return.

Loading BDRX total return...

As of 2026-05-08

Returns at a Glance

Period	Total Return	CAGR	Price Only	Div. Contrib.	$10K →
YTD	-60.49%	—	-60.49%	—	$3,951
1Y	-92.96%	-92.96%	-92.96%	—	$704
3Y	-99.98%	-93.97%	-99.98%	—	$2
5Y	-100.00%	-91.29%	-100.00%	—	$0
10Y	-100.00%	-70.49%	-100.00%	—	$0
15Y	-100.00%	-55.68%	-100.00%	—	$0
20Y	-100.00%	-45.68%	-100.00%	—	$0
30Y	-100.00%	-33.43%	-100.00%	—	$0

Risk & Highlights

Best Year+0.00%2018

Worst Year-99.12%2023

Max Drawdown-96.95%2025-05-09 → 2026-01-24

Annual Returns

Year	Total Return	Price Return	Div.	S&P 500	vs S&P
2026YTD	-56.10%	-56.10%	—	+0.41%	-56.5pp
2025	-94.45%	-94.45%	—	+16.64%	-111.1pp
2024	-93.98%	-93.98%	—	+24.00%	-118.0pp
2023	-99.12%	-99.12%	—	+24.81%	-123.9pp
2022	-82.72%	-82.72%	—	-19.95%	-62.8pp

BDRX underperformed the S&P 500 by 123.33pp over the past year (-92.96% vs +30.37%).

Loading summary...

BDRX Peers' Total Return

Accurate peer set · 10 comparable names

Name	Mkt Cap	30D Rtn	YTD Total Rtn	1Y Total Rtn	Div Contrib	3Y Total Rtn	5Y Total Rtn	10Y Total Rtn
BDRXBiodexa Pharmaceuticals Plc	$1M	+45.1%	-60.5%	-93.0%	—	-100.0%	-100.0%	-100.0%
SIGASIGA Technologies, Inc.	$339M	+4.4%	-15.0%	+1.5%	+11.4pp	+22.2%	+1.4%	+764.0%
NUVBNuvation Bio Inc.	$1.7B	+6.9%	-43.8%	+136.3%	—	+197.5%	-58.3%	-51.8%
IMVTImmunovant, Inc.	$5.5B	+10.6%	+5.1%	+96.1%	—	+40.9%	+62.4%	+173.6%
PRAXPraxis Precision Medicines, Inc.	$9.6B	+8.7%	+16.4%	+775.0%	—	+1976.5%	-20.8%	-20.1%
ACADACADIA Pharmaceuticals Inc.	$3.9B	+2.2%	-13.7%	+52.4%	—	+4.7%	+7.1%	-22.9%
INVAInnoviva, Inc.	$1.9B	-2.1%	+14.7%	+21.7%	—	+95.2%	+94.4%	+94.9%
AVXLAnavex Life Sciences Corp.	$289M	+1.3%	-15.2%	-63.2%	—	-62.9%	-72.4%	-25.7%
CORTCorcept Therapeutics Incorporated	$5.5B	+22.5%	+33.6%	-27.5%	—	+114.9%	+141.9%	+929.2%
AGENAgenus Inc.	$132M	-7.6%	+16.1%	+27.1%	—	-88.2%	-93.9%	-94.3%
IQVIQVIA Holdings Inc.	$30.3B	+4.7%	-20.7%	+16.5%	—	-5.9%	-23.8%	+166.5%

Compare:BDRX vs SIGA BDRX vs NUVB BDRX vs IMVT BDRX vs SIGA vs NUVB

About BDRX Dividend Returns

Biodexa Pharmaceuticals Plc (BDRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends.

How We Calculate Total Return

Our total return calculator simulates dividend reinvestment (DRIP) by assuming each dividend payment is used to purchase additional shares at the closing price on the ex-dividend date. This methodology provides an accurate representation of how a dividend reinvestment plan would perform.

Frequently Asked Questions

Q1What is the total return of BDRX over the past year?

Biodexa Pharmaceuticals Plc (BDRX) delivered a return of -92.96% over the past year. Since BDRX does not currently pay dividends, the total return equals the price-only return.

Q2How much would $10,000 invested in BDRX be worth today?

A $10,000 investment in Biodexa Pharmaceuticals Plc one year ago would be worth $704 today, representing a loss of $9,296.

Q3Does BDRX pay dividends?

Biodexa Pharmaceuticals Plc (BDRX) does not currently pay dividends. Many growth-focused companies reinvest profits back into the business rather than distributing them as dividends. For BDRX, the total return equals the price-only return.

Q4Did BDRX beat the S&P 500?

No, Biodexa Pharmaceuticals Plc (BDRX) underperformed the S&P 500 by 123.33 percentage points over the past year. BDRX delivered a total return of -92.96%, compared to the S&P 500's 30.37%. This means a passive S&P 500 index fund outperformed BDRX by 123.33pp during this period.

Q5What is BDRX's worst drawdown?

Biodexa Pharmaceuticals Plc (BDRX) experienced a maximum drawdown of -96.95% over the past year, declining from its peak on 2025-05-09 to its trough on 2026-01-24. The stock has not yet fully recovered to its prior peak. Maximum drawdown measures the worst peak-to-trough decline and is an important risk metric for investors.

Q6What is BDRX's long-term total return over 10, 20, or 30 years?

Here are Biodexa Pharmaceuticals Plc (BDRX)'s long-term returns with dividends reinvested. Over 10 years, the total return is -100.0% (-70.5% CAGR) — $10,000 would have grown to $0. Over 20 years: -100.0% total return (-45.7% CAGR) — $10,000 → $0. Over 30 years: -100.0% total return (-33.4% CAGR) — $10,000 → $0. Long-term investors benefit from compounding: dividends buy additional shares, which generate their own dividends, creating an exponential growth effect.

Q7What was BDRX's best and worst year?

Biodexa Pharmaceuticals Plc's best calendar year was 2018 with a total return of 0.0%. Its worst year was 2023 with a total return of -99.1%. This range shows the volatility investors should expect — the difference between the best and worst year is 99.1 percentage points.